Drugmakers, insurers, hospitals, pharmacies, medical devices, clinical updates, and healthcare business leaders.
The pharmaceutical company said CFO Dave Denton, who joined Pfizer in 2022 from Lowe’s, will depart for an unspecified “professional opportunity” in consumer goods.
THE APEX TIMES
THE APEX TIMES
The company plans to name an interim chief financial officer effective August 16 as it searches for a permanent CFO.
THE APEX TIMES
The two companies said Charles River Laboratories will join Lilly TuneLab to support the platform with nonclinical testing capabilities, a step aimed at improving how AI and machine-learning models translate into drug candidates earlier in development.
THE APEX TIMES
The drugmaker says Chief Financial Officer Dave Denton will leave Pfizer on August 15, opening a leadership transition at a time when investors are watching how management plans to fund its pipeline and investments.
THE APEX TIMES
A June 15 update highlighted early clinical readouts tied to AJX-101, keeping attention on how Eli Lilly’s pipeline could support earnings growth over the next several years.
THE APEX TIMES
The Japan-based discovery firm said it has entered a collaboration with Eli Lilly’s Lilly TuneLab, indicating continued use of machine-learning tools in early-stage drug hunting.
THE APEX TIMES
The announcement, reported June 18, 2026, points to continued capital spending by Johnson & Johnson as it expands manufacturing capacity for contact lenses under its consumer health and medical products portfolio.
THE APEX TIMES
The biotech’s stock rose sharply Wednesday, adding to gains from the prior four sessions as investors looked to upcoming remarks at its Investor Day.
THE APEX TIMES
UnitedHealth Group (UNH) ended the latest trading day down 1.99% to $399.53, a larger decline than the overall market, according to a report carried by Yahoo Finance.
